Development of a multisystem surveillance database for transfusion-transmitted infections among blood donors in the United States

Transfusion

Volumn 56, Issue 11, 2016, Pages 2781-2789

  Dodd, Roger Y ^a   Notari, Edward P ^a   Nelson, Diane ^a   Foster, Gregory A ^b   Krysztof, David E ^b   Kaidarova, Zhanna ^c   Milan Benson, Lisa ^d   Kessler, Debra A ^d   Shaz, Beth H ^d   Vahidnia, Farnaz ^c   Custer, Brian ^c,e   Stramer, Susan L ^b  

^a HOLLAND LABORATORY   (United States)

^b AMERICAN RED CROSS   (United States)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^d NEW YORK BLOOD CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ALGORITHM; ARTICLE; BLOOD DONOR; CONSENSUS; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DISEASE SURVEILLANCE; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; INFECTION; MAJOR CLINICAL STUDY; MALE; TRANSFUSION; TRANSFUSION TRANSMITTED INFECTION; UNITED STATES; ADVERSE EFFECTS; BLOOD TRANSFUSION; EPIDEMIOLOGICAL MONITORING; FACTUAL DATABASE; SEX DIFFERENCE; TRANSMISSION; VIRUS DISEASES;

BLOOD DONORS; BLOOD TRANSFUSION; DATABASES, FACTUAL; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; MALE; SEX FACTORS; UNITED STATES; VIRUS DISEASES;

EID: 84994234469     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13759     Document Type: Article

References (7)

1. Zou S, Stramer SL, Dodd RY. Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations. Transfus Med Rev 2012;26:119–28.
2. Stramer SL, Glynn SA, Kleinman SH, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004;351:760–8.
3. Chang YB, Kaidarova Z, Hindes D, et al. Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors—United States, 2000-2009. J Infect Dis 2014;209:523–31.
4. Revised recommendations for reducing the risk of human immunodeficiency virus transmission by blood and blood products: guidance for industry [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2015 [cited 2016 May 2]. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM446580.pdf.
5. Custer B, Stramer SL, Glynn S, et al. Transfusion-transmissible infection monitoring system: a tool to monitor changes in blood safety. Transfusion 2016; DOI: 10:1111/trf.13632.
6. Stramer SL, Notari EP, Krysztof DE, et al. Hepatitis B virus tested by minipool nucleic acid testing: does it improve blood safety? Transfusion 2013;53:2449–58.
7. Custer B, Kessler D, Vahidnia F, et al. Risk factors for retrovirus and hepatitis virus infections in accepted blood donors. Transfusion 2015;55:1098–107.